Shock and Kill Approach can be Effective in Curing Hidden HIV-Infected Cells

by Kathy Jones on  August 15, 2014 at 9:38 PM AIDS/HIV News   - G J E 4
Adopting a 'shock and kill' approach in which the dormant HIV viruses are activated with the help of drugs called inducers and combined with virus-fighting antibodies can be effective in curing the hidden reservoir of HIV-1 infected cells in humans, a new study published in the journal Cell reveals.
 Shock and Kill Approach can be Effective in Curing Hidden HIV-Infected Cells
Shock and Kill Approach can be Effective in Curing Hidden HIV-Infected Cells

"This is the first time the shock-and-kill approach designed to flush out latent viruses has seen tangible success in an animal model," says senior study author Michel Nussenzweig of The Rockefeller University. "The concept will need to be further tested through clinical studies in infected individuals."

Currently, HIV-1 infection can be controlled through a combination of antiretroviral drugs that act at different stages of the virus life cycle. However, these drugs must be taken for life because they do not eliminate inactive viruses within cells. If a patient stops antiretroviral therapy, the previously dormant viruses become activated and detectable in the blood. All previous attempts to alter the HIV-1 reservoir in living animals by combining antiretroviral therapy with other drugs, including inducers that activate genes in latent viruses, have failed.

One potential strategy to overcome this hurdle involves the use of broadly neutralizing antibodies, which can engage the host immune system to kill infected cells. To test this approach and compare it with others, Nussenzweig and his team injected HIV-1 into mice containing human immune cells and treated them with broadly neutralizing antibodies, inducers, antiretroviral drugs, or combinations of these therapies.

The vast majority of mice treated with antiretroviral therapy alone showed detectable virus levels in the blood after the end of treatment. Similarly, almost all mice treated with broadly neutralizing antibodies combined with a single inducer showed viral rebound after the end of treatment. By contrast, the majority of mice treated with a combination of broadly neutralizing antibodies and three different inducers did not show signs of viral rebound.

"Disrupting the establishment and maintenance of the latent reservoir is a necessary step in curing HIV-1 infection," says lead study author Ariel Halper-Stromberg of The Rockefeller University. "This study shows that combinations of antibodies and inducers can play a significant role in this process."

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

View All